Lnc-C/EBPβ Modulates Differentiation of MDSCs Through Downregulating IL4i1 With C/EBPβ LIP and WDR5
Myeloid-derived suppressor cells (MDSCs), which play an important role in tumor and inflammatory diseases, are divided into two subsets CD11b Ly6C Ly6G monocytic MDSC (Mo-MDSC) and CD11b Ly6C Ly6G polymorphonuclear MDSC (PMN-MDSC) with different immunosuppressive function. However, it is poorly unde...
Gespeichert in:
Veröffentlicht in: | Frontiers in immunology 2019-07, Vol.10, p.1661-1661 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Myeloid-derived suppressor cells (MDSCs), which play an important role in tumor and inflammatory diseases, are divided into two subsets CD11b
Ly6C
Ly6G
monocytic MDSC (Mo-MDSC) and CD11b
Ly6C
Ly6G
polymorphonuclear MDSC (PMN-MDSC) with different immunosuppressive function. However, it is poorly understood the mechanism(s) to control differentiation of Mo-MDSCs and PMN-MDSCs. Here, we found that
β may promote PMN-MDSC but impede differentiation of Mo-MDSCs
and
. We demonstrated that
β mediated differentiation of MDSCs was through downregulating multiple transcripts such as IL4il.
β not only bound to C/EBPβ isoform LIP to inhibit the activation of C/EBPβ but also interacted with WDR5 to interrupt the enrichment of H3K4me3 mark on the promoter region of IL4i1. Data also imply that conserved homo
β has a similar function with mouse
β. Since MDSC subsets exert different suppressive function,
β may be acted as a potential therapeutic target for inflammatory and tumor-associated diseases. |
---|---|
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2019.01661 |